Literature DB >> 11703081

Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates.

J G Scammell1, W B Denny, D L Valentine, D F Smith.   

Abstract

Many New World primates have high circulating levels of cortisol to compensate for the expression of glucocorticoid receptors (GRs) with low activity. Recent work in squirrel monkeys has suggested that this may be due to either the expression of GRs that are transcriptionally incompetent or the expression of an FK506-binding immunophilin that inhibits GR binding. The goal of this study was to resolve this controversy by determining the molecular basis of glucocorticoid resistance not only in species of squirrel monkeys but also in other glucocorticoid-resistant New World primates. First, the transcriptional activity of the GR from the Bolivian squirrel monkey was compared to that of the human GR. Incubation of COS-7 cells transfected with the squirrel monkey GR with 10 nM dexamethasone resulted in a robust stimulation of MMTV-luciferase activity (up to 260-fold), which was similar in magnitude to that achieved with the human GR. Second, the effect of FK506 on GR binding was determined in cytosol from cells from two species of squirrel monkeys as well as glucocorticoid-resistant cotton-top tamarins and owl monkeys. Incubation with 10 microM FK506 increased GR binding by at least 4-fold in cytosol from cells of each of the New World primates but had no effect on GR binding in cytosol from human WI-38 VA13 cells. Third, Western blots showed elevated expression of FKBP51 in New World primate cells and liver samples from two squirrel monkey species. On the other hand, the levels of FKBP52 were significantly lower in cells and liver from New World primates. The sequences of FKBP51 from the cotton-top tamarin, owl monkey and squirrel monkey are closely related and share differences from the human, rhesus monkey, mouse, and lemur FKBP51 sequences in the same 18 positions. Fourth, the relative activities of FKBP51 from the cotton-top tamarin, owl monkey and squirrel monkey were determined in cytosol mixing and GR transactivation studies and showed that FKBP51 from each of these primates was a potent inhibitor of GR activity. These results indicate that the elevated expression of FKBP51 contributes to glucocorticoid resistance in three New World primate genera. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11703081     DOI: 10.1006/gcen.2001.7696

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  74 in total

1.  The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo.

Authors:  Daniel L Riggs; Patricia J Roberts; Samantha C Chirillo; Joyce Cheung-Flynn; Viravan Prapapanich; Thomas Ratajczak; Richard Gaber; Didier Picard; David F Smith
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

Review 2.  Organization and function of the FKBP52 and FKBP51 genes.

Authors:  Donna L Cioffi; Tina R Hubler; Jonathan G Scammell
Journal:  Curr Opin Pharmacol       Date:  2011-04-21       Impact factor: 5.547

3.  Mining microarrays for metabolic meaning: nutritional regulation of hypothalamic gene expression.

Authors:  Charles V Mobbs; Kelvin Yen; Jason Mastaitis; Ha Nguyen; Elizabeth Watson; Elisa Wurmbach; Stuart C Sealfon; Andrew Brooks; Stephen R J Salton
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

4.  Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids.

Authors:  Tina R Hubler; Jonathan G Scammell
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667

5.  Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51.

Authors:  Julie M Caldwell; Carine Blanchard; Margaret H Collins; Philip E Putnam; Ajay Kaul; Seema S Aceves; Catherine A Bouska; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2010-04       Impact factor: 10.793

Review 6.  Versatile TPR domains accommodate different modes of target protein recognition and function.

Authors:  Rudi Kenneth Allan; Thomas Ratajczak
Journal:  Cell Stress Chaperones       Date:  2010-12-09       Impact factor: 3.667

Review 7.  Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational Implications.

Authors:  Anthony S Zannas; Tobias Wiechmann; Nils C Gassen; Elisabeth B Binder
Journal:  Neuropsychopharmacology       Date:  2015-08-13       Impact factor: 7.853

8.  Association of FKBP5 polymorphisms and resting-state activity in a frontotemporal-parietal network.

Authors:  R A Bryant; K L Felmingham; B Liddell; P Das; G S Malhi
Journal:  Transl Psychiatry       Date:  2016-10-18       Impact factor: 6.222

Review 9.  The role of FKBP5 in mood disorders: action of FKBP5 on steroid hormone receptors leads to questions about its evolutionary importance.

Authors:  John C O'Leary; Bo Zhang; John Koren; Laura Blair; Chad A Dickey
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-12       Impact factor: 4.388

10.  Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes.

Authors:  Cindy R Sinars; Joyce Cheung-Flynn; Ronald A Rimerman; Jonathan G Scammell; David F Smith; Jon Clardy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.